Landscape phage fusion protein-modified pharmaceutical nanocarriers for targeted and cytoplasmic delivery of chemotherapeutics to breast cancer cells in vitro and in vivo
Objective : Conventional chemotherapy is often accompanied by severe side-effects in cancer treatment owing to its inability to kill tumor cells specifically. The use of targeted pharmaceutical nanocarriers has improved the pharmacokinetic and pharmacodynamic properties of chemotherapy. Ongoing chal...
| Published: |
|
|---|---|
| Online Access: | http://hdl.handle.net/2047/d20002706 |